Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

E Robson

Showing results (141-150 of 352) with videos related to

Pageof 36
Sort By:
NIDA Research Monograph|January 1, 1986
Recent developments in bioassay using selective ligands and selective in vitro preparationsH W Kosterlitz, A D Corbett, M G Gillan, et al.
British Journal of Pharmacology|September 1, 1984
Selectivities of opioid peptide analogues as agonists and antagonists at the delta-receptorA D Corbett, M G Gillan, H W Kosterlitz, et al.
American Journal of Surgery|October 18, 2025
Selective visualization of the recurrent laryngeal nerve during parathyroidectomyMarina E Robson Chase, Mackenzie Donoho, Oliver J Fackelmayer, et al.
Journal of Thoracic Oncology : Official Publication of the International Association for the Study of Lung Cancer|December 31, 2019
Novel Germline Mutations in DNA Damage Repair in Patients with Malignant Pleural MesotheliomasRobin Guo, Mariel DuBoff, Gowtham Jayakumaran, et al.
Journal of Oncology Practice|June 20, 2017
Interest and Attitudes of Patients With Advanced Cancer With Regard to Secondary Germline Findings From Tumor Genomic ProfilingJada G Hamilton, Elyse Shuk, Margaux C Genoff, et al.
Future Oncology (London, England)|August 22, 2025
Patient characteristics, treatment patterns, and clinical outcomes in HER2-negative early breast cancer by germline BRCA statusJay A Andersen, Jagadeswara Rao Earla, Nicole Fulcher, et al.
Journal of Thoracic Oncology : Official Publication of the International Association for the Study of Lung Cancer|May 17, 2012
Screening for germline EGFR T790M mutations through lung cancer genotypingGeoffrey R Oxnard, Vincent A Miller, Mark E Robson, et al.
Journal of the American College of Surgeons|January 14, 2026
Analysis of Surgical Outcomes During a Period of Intravenous Fluid Restriction as a Result of a National ShortageJacob C Hubbuch, Daniel L Davenport, Alexis Nickols, et al.
Breast Cancer Research and Treatment|March 12, 2010
Absence of genomic BRCA1 and BRCA2 rearrangements in Ashkenazi breast and ovarian cancer familiesZsofia K Stadler, Emmanuel Saloustros, Nichole A L Hansen, et al.
The Cochrane Database of Systematic Reviews|April 22, 2021
PARP (Poly ADP-Ribose Polymerase) inhibitors for locally advanced or metastatic breast cancerAmelia M Taylor, David Lok Hang Chan, Martin Tio, et al.
Pageof 36

Showing results (141-150 of 352) with videos related to

Sort By:
Pageof 36
NIDA Research Monograph|January 1, 1986
Recent developments in bioassay using selective ligands and selective in vitro preparationsH W Kosterlitz, A D Corbett, M G Gillan, et al.
British Journal of Pharmacology|September 1, 1984
Selectivities of opioid peptide analogues as agonists and antagonists at the delta-receptorA D Corbett, M G Gillan, H W Kosterlitz, et al.
American Journal of Surgery|October 18, 2025
Selective visualization of the recurrent laryngeal nerve during parathyroidectomyMarina E Robson Chase, Mackenzie Donoho, Oliver J Fackelmayer, et al.
Journal of Thoracic Oncology : Official Publication of the International Association for the Study of Lung Cancer|December 31, 2019
Novel Germline Mutations in DNA Damage Repair in Patients with Malignant Pleural MesotheliomasRobin Guo, Mariel DuBoff, Gowtham Jayakumaran, et al.
Journal of Oncology Practice|June 20, 2017
Interest and Attitudes of Patients With Advanced Cancer With Regard to Secondary Germline Findings From Tumor Genomic ProfilingJada G Hamilton, Elyse Shuk, Margaux C Genoff, et al.
Future Oncology (London, England)|August 22, 2025
Patient characteristics, treatment patterns, and clinical outcomes in HER2-negative early breast cancer by germline BRCA statusJay A Andersen, Jagadeswara Rao Earla, Nicole Fulcher, et al.
Journal of Thoracic Oncology : Official Publication of the International Association for the Study of Lung Cancer|May 17, 2012
Screening for germline EGFR T790M mutations through lung cancer genotypingGeoffrey R Oxnard, Vincent A Miller, Mark E Robson, et al.
Journal of the American College of Surgeons|January 14, 2026
Analysis of Surgical Outcomes During a Period of Intravenous Fluid Restriction as a Result of a National ShortageJacob C Hubbuch, Daniel L Davenport, Alexis Nickols, et al.
Breast Cancer Research and Treatment|March 12, 2010
Absence of genomic BRCA1 and BRCA2 rearrangements in Ashkenazi breast and ovarian cancer familiesZsofia K Stadler, Emmanuel Saloustros, Nichole A L Hansen, et al.
The Cochrane Database of Systematic Reviews|April 22, 2021
PARP (Poly ADP-Ribose Polymerase) inhibitors for locally advanced or metastatic breast cancerAmelia M Taylor, David Lok Hang Chan, Martin Tio, et al.
Pageof 36